270 related articles for article (PubMed ID: 1334483)
1. Purification and characterization of DNA topoisomerase IV in Escherichia coli.
Kato J; Suzuki H; Ikeda H
J Biol Chem; 1992 Dec; 267(36):25676-84. PubMed ID: 1334483
[TBL] [Abstract][Full Text] [Related]
2. New topoisomerase essential for chromosome segregation in E. coli.
Kato J; Nishimura Y; Imamura R; Niki H; Hiraga S; Suzuki H
Cell; 1990 Oct; 63(2):393-404. PubMed ID: 2170028
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions.
Peng H; Marians KJ
J Biol Chem; 1993 Nov; 268(32):24481-90. PubMed ID: 8227000
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
Pan XS; Fisher LM
J Bacteriol; 1996 Jul; 178(14):4060-9. PubMed ID: 8763932
[TBL] [Abstract][Full Text] [Related]
5. Requirement of topoisomerase IV parC and parE genes for cell cycle progression and developmental regulation in Caulobacter crescentus.
Ward D; Newton A
Mol Microbiol; 1997 Dec; 26(5):897-910. PubMed ID: 9426128
[TBL] [Abstract][Full Text] [Related]
6. Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IV.
Akasaka T; Onodera Y; Tanaka M; Sato K
Antimicrob Agents Chemother; 1999 Mar; 43(3):530-6. PubMed ID: 10049263
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones.
Pan XS; Fisher LM
Antimicrob Agents Chemother; 1999 May; 43(5):1129-36. PubMed ID: 10223925
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerases I and III inhibit R-loop formation to prevent unregulated replication in the chromosomal Ter region of Escherichia coli.
Brochu J; Vlachos-Breton É; Sutherland S; Martel M; Drolet M
PLoS Genet; 2018 Sep; 14(9):e1007668. PubMed ID: 30222737
[TBL] [Abstract][Full Text] [Related]
9. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
Pan XS; Yague G; Fisher LM
Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolones inhibit preferentially Streptococcus pneumoniae DNA topoisomerase IV than DNA gyrase native proteins.
Fernandez-Moreira E; Balas D; Gonzalez I; de la Campa AG
Microb Drug Resist; 2000; 6(4):259-67. PubMed ID: 11272253
[TBL] [Abstract][Full Text] [Related]
11. Decatenation activity of topoisomerase IV during oriC and pBR322 DNA replication in vitro.
Peng H; Marians KJ
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8571-5. PubMed ID: 8104339
[TBL] [Abstract][Full Text] [Related]
12. Escherichia coli DNA topoisomerase I mutants: increased supercoiling is corrected by mutations near gyrase genes.
Pruss GJ; Manes SH; Drlica K
Cell; 1982 Nov; 31(1):35-42. PubMed ID: 6297751
[TBL] [Abstract][Full Text] [Related]
13. DNA gyrase and DNA topoisomerase of Bacillus subtilis: expression and characterization of recombinant enzymes encoded by the gyrA, gyrB and parC, parE genes.
Barnes MH; LaMarr WA; Foster KA
Protein Expr Purif; 2003 Jun; 29(2):259-64. PubMed ID: 12767818
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.
Zechiedrich EL; Khodursky AB; Cozzarelli NR
Genes Dev; 1997 Oct; 11(19):2580-92. PubMed ID: 9334322
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of Escherichia coli topoisomerase IV. II. ATPase negative mutants of parE induce hyper-DNA cleavage.
Nurse P; Bahng S; Mossessova E; Marians KJ
J Biol Chem; 2000 Feb; 275(6):4104-11. PubMed ID: 10660570
[TBL] [Abstract][Full Text] [Related]
16. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F
Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
[TBL] [Abstract][Full Text] [Related]
17. [DNA supercoiling and topoisomerases in Escherichia coli].
Gómez-Eichelmann MC; Camacho-Carranza R
Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
[TBL] [Abstract][Full Text] [Related]
18. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.
Belland RJ; Morrison SG; Ison C; Huang WM
Mol Microbiol; 1994 Oct; 14(2):371-80. PubMed ID: 7830580
[TBL] [Abstract][Full Text] [Related]
19. Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan, Iran.
Azargun R; Soroush Barhaghi MH; Samadi Kafil H; Ahangar Oskouee M; Sadeghi V; Memar MY; Ghotaslou R
J Glob Antimicrob Resist; 2019 Jun; 17():39-43. PubMed ID: 30445211
[TBL] [Abstract][Full Text] [Related]
20. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
Bagel S; Hüllen V; Wiedemann B; Heisig P
Antimicrob Agents Chemother; 1999 Apr; 43(4):868-75. PubMed ID: 10103193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
